Surface coatings that protect.
Technologies that lead.

Biomedical coatings that protect. Technologies that lead.

TekCyte is a leader in the development and commercialisation of advanced, high-performance surface coatings that address critical problems across medical and industrial applications.

Our coating technologies are designed to address complex surface fouling and contamination challenges, and to create value across multiple applications.

High-performance coating solutions
addressing infection and inflammation

TekCyte’s two passive coating solutions, Nilbax™ and BIOINVISIBLE™, target distinct healthcare risks and issues associated with implanted devices and surgical instruments.

Nilbax™ – minimising infection risk

BIOINVISIBLE™ – reducing thrombosis & fibrosis

Our advanced coating solutions are drug-free, non-leaching and hydrophilic, offering long-lasting protection without releasing active substances into the body.

A breakthrough in biofilm prevention

Implant-related infections remain a persistent clinical and economic burden. From dental implants and trauma screws to orthopaedic components, bacterial contamination of implant surfaces is a leading cause of post-operative infection, implant failure and revision surgery.

Nilbax™ is TekCyte’s advanced coating technology for reducing bacterial contamination on medical implant surfaces. This passive, functionalised coating creates a protective surface barrier on medical implants that reduces bacterial adhesion and helps prevent persistent biofilm formation.

By lowering the risk of biofilm-related infection, Nilbax™ can reduce the need for antibiotics and revision surgery – supporting better outcomes for patients.

Nilbax™ is drug-free, non-toxic and biocompatible.

What Nilbax™ delivers:

Drastically reduces bacterial adhesion that leads to biofilm and infection
Acts passively – no antibiotics, silver or active biological agents
Lowers risk of antimicrobial resistance by avoiding drug-based solutions and the need for additional antibiotic use
Chemically stable and ready for commercial-scale production
Suitable for several device materials including as titanium and stainless steel
Compatible with many standard sterilisation methods
Patented and available for licensing – giving your product a competitive edge

Coating services that support product innovation

TekCyte provides contract coating services to support development and innovation. We work from early concept through to clinical rollout, delivering expert, responsive solutions for medical device companies, research institutions and manufacturers with specialised surface performance needs.

Our services include:

TekCyte coatings are trusted by leading medtech companies and research teams across orthopaedics, cell therapy, diagnostics and surgical innovation. We’ve coated components for use in research and product development – demonstrating our ability to translate laboratory science into real-world application.

With deep technical insight and expertise, a collaborative model and a proven track record, the TekCyte team helps you reduce risk, accelerate development and support successful product delivery.

Why TekCyte

World leader in passive, drug-free coating technologies

International patent portfolio and regulatory-aligned processes

Trusted by global medical device and biotech companies

Supports TGA, FDA, EU MDR, REACH and sustainability-aligned product development

Proven results based on pre-clinical studies showing significant reduction in bacterial contamination, clotting and fibrosis on coated materials

TekCyte is a leader in the development and commercialisation of advanced, high-performance medical and industrial surface coatings.

Flexible licensing and engagement models

TekCyte offers flexible engagement models to suit your product lifecycle and commercial goals:

Technology licensing – for Nilbax™ and BIOINVISIBLE™

Proof-of-concept evaluations – for early testing and validation

Collaborative development – for custom or strategic projects

Fee-for-service coating – for fast, technical support during prototyping

Our staged approach is designed to reduce regulatory complexity and support confident integration.

Global collaborations with purpose

TekCyte works with leading innovators across medical, biotech and industrial sectors to bring advanced coating science into real-world application.

We have collaborated with organisations including Saint-Gobain, Cynata Therapeutics, Alyra Biotech and Osmoflow.

Using world-leading surface technologies, the TekCyte team contributes deep technical expertise and scientific insight to a wide range of commercial projects and research collaborations, supporting both early-stage innovation and commercial-scale integration.

These collaborations reflect our reputation for high-quality, flexibility and results-driven execution in addressing complex surface challenges.

See how our coatings perform in real-world applications.

Our collaborations

Using world-leading surface technologies, the TekCyte team contributes their extensive knowledge and know-how to a diverse range of commercial projects and research collaborations.